Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway

References

• Ogurtsova K, Da Rocha Fernandes JD, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:1–12. doi: 10.1016/j.diabres.2017.03.024.
   PubMed Web of Science ®Google Scholar
• Koye DN, Magliano DJ, Nelson RG, et al. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis. 2018;25(2):121–132. doi: 10.1053/j.ackd.2017.10.011.
   PubMed Web of Science ®Google Scholar
• Reidy K, Kang HM, Hostetter T, et al. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014;124(6):2333–2340. doi: 10.1172/JCI72271.
   PubMed Web of Science ®Google Scholar
• Ye H, Bai X, Gao H, et al. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy. J Diabetes Complications. 2014;28(1):96–100. doi: 10.1016/j.jdiacomp.2013.08.006.
   PubMed Web of Science ®Google Scholar
• Griffin TP, Martin WP, Islam N, et al. The promise of mesenchymal stem cell therapy for diabetic kidney disease. Curr Diab Rep. 2016;16(5):42. doi: 10.1007/s11892-016-0734-6.
   PubMed Web of Science ®Google Scholar
• Nakatogawa H, Suzuki K, Kamada Y, et al. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol. 2009;10(7):458–467. doi: 10.1038/nrm2708.
   PubMed Web of Science ®Google Scholar
• He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43(1):67–93. doi: 10.1146/annurev-genet-102808-114910.
   PubMed Web of Science ®Google Scholar
• Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med. 2013;368(7):651–662. doi: 10.1056/NEJMra1205406.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ng S, Wang J, et al. Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways. Autophagy. 2015;11(4):629–642. doi: 10.1080/15548627.2015.1023981.
   PubMed Web of Science ®Google Scholar
• Ravanan P, Srikumar IF, Talwar P. Autophagy: the spotlight for cellular stress responses. Life Sci. 2017;188:53–67. doi: 10.1016/j.lfs.2017.08.029.
   PubMed Web of Science ®Google Scholar
• Kume S, Koya D. Autophagy: a novel therapeutic target for diabetic nephropathy. Diabetes Metab J. 2015;39(6):451–460. doi: 10.4093/dmj.2015.39.6.451.
   PubMed Web of Science ®Google Scholar
• Dai H, Liu Q, Liu B. Research progress on mechanism of podocyte depletion in diabetic nephropathy. J Diabetes Res. 2017;2017:2615286. doi: 10.1155/2017/2615286.
   PubMed Web of Science ®Google Scholar
• Pontrelli P, Oranger A, Barozzino M, et al. Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysine 63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy. J Mol Med. 2018;96(7):645–659. doi: 10.1007/s00109-018-1656-3.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Iwano M, Suzuki D, et al. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis. 2009;54(4):653–664. doi: 10.1053/j.ajkd.2009.05.009.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Gan Y, Huang WF, et al. Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease. Cell Death Dis. 2019;10(11):806. doi: 10.1038/s41419-019-2002-6.
   PubMedGoogle Scholar
• Wang W, Sun W, Cheng Y, et al. Role of sirtuin-1 in diabetic nephropathy. J Mol Med . 2019;97(3):291–309. doi: 10.1007/s00109-019-01743-7.
   PubMed Web of Science ®Google Scholar
• Heras-Sandoval D, Pérez-Rojas JM, Hernández-Damián J, et al. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 2014;26(12):2694–2701. doi: 10.1016/j.cellsig.2014.08.019.
   PubMed Web of Science ®Google Scholar
• Qiao L, Shao J. SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J Biol Chem. 2006;281(52):39915. doi: 10.1074/jbc.M607215200.
   PubMed Web of Science ®Google Scholar
• Ji L, Wang Q, Huang F, et al. FOXO1 overexpression attenuates tubulointerstitial fibrosis and apoptosis in diabetic kidneys by ameliorating oxidative injury via TXNIP-TRX. Oxid Med Cell Longev. 2019;2019:3286928–3286914. doi: 10.1155/2019/3286928.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147. doi: 10.1126/science.284.5411.143.
   PubMed Web of Science ®Google Scholar
• Shi Y, Hu G, Su J, et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 2010;20(5):510–518. doi: 10.1038/cr.2010.44.
   PubMed Web of Science ®Google Scholar
• Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98(5):1076–1084. doi: 10.1002/jcb.20886.
   PubMed Web of Science ®Google Scholar
• Yue Y, Yeh JN, Chiang JY, et al. Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat. Stem Cell Res Ther. 2022;13(1):186. doi: 10.1186/s13287-022-02857-5.
   PubMed Web of Science ®Google Scholar
• Ebrahim N, Ahmed IA, Hussien NI, et al. Mesenchymal stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway. Cells. 2018;7(12):226. doi: 10.3390/cells7120226.
   PubMed Web of Science ®Google Scholar
• Jung J, Choi JH, Lee Y, et al. Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4 -injured rat liver model via increased autophagic mechanism. Stem Cells. 2013;31(8):1584–1596. doi: 10.1002/stem.1396.
   PubMed Web of Science ®Google Scholar
• Li J, Zhou J, Zhang D, et al. Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury. J Cell Mol Med. 2015;19(10):2341–2351. doi: 10.1111/jcmm.12638.
   PubMed Web of Science ®Google Scholar
• Zhao K, Hao H, Liu J, et al. Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy. Cell Death Dis. 2015;6(9):e1885–e1885. doi: 10.1038/cddis.2015.230.
   PubMedGoogle Scholar
• Afkarian M, Zelnick LR, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. Jama. 2016;316(6):602–610. doi: 10.1001/jama.2016.10924.
   PubMed Web of Science ®Google Scholar
• Low SK, Sum CF, Yeoh LY, et al. Prevalence of chronic kidney disease in adults with type 2 diabetes mellitus. Ann Acad Med Singap. 2015;44(5):164–171. doi: 10.47102/annals-acadmedsg.V44N5p164.
   PubMed Web of Science ®Google Scholar
• Xiao L, Wang M, Yang S, et al. A glimpse of the pathogenetic mechanisms of Wnt/β-catenin signaling in diabetic nephropathy. Biomed Res Int. 2013;2013:987064–987067. doi: 10.1155/2013/987064.
   PubMed Web of Science ®Google Scholar
• Tu Q, Li Y, Jin J, et al. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells. Pharm Biol. 2019;57(1):778–786. doi: 10.1080/13880209.2019.1688843.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li R, Shi W, et al. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice. Br J Pharmacol. 2013;170(2):426–439. doi: 10.1111/bph.12292.
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Mimura I, Tanaka T, et al. Treatment of diabetic kidney disease: current and future. Diabetes Metab J. 2021;45(1):11–26. doi: 10.4093/dmj.2020.0217.
   PubMed Web of Science ®Google Scholar
• Frampton JE. Finerenone: first approval. Drugs. 2021;81(15):1787–1794. doi: 10.1007/s40265-021-01599-7.
   PubMed Web of Science ®Google Scholar
• Lee WS, Kim HJ, Kim KI, et al. Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, Placebo-Controlled clinical trial. Stem Cells Transl Med. 2019;8(6):504–511. doi: 10.1002/sctm.18-0122.
   PubMed Web of Science ®Google Scholar
• Chen S, Cui G, Peng C, et al. Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats. Stem Cell Res Ther. 2018;9(1):110. doi: 10.1186/s13287-018-0846-9.
   PubMedGoogle Scholar
• Wang D, Huang S, Yuan X, et al. The regulation of the treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol. 2017;14(5):423–431. doi: 10.1038/cmi.2015.89.
   PubMed Web of Science ®Google Scholar
• Li H, Rong P, Ma X, et al. Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy. Life Sci. 2018;215:113–118. doi: 10.1016/j.lfs.2018.11.001.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li K, Liu X, et al. Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats. Stem Cells Dev. 2013;22(23):3074–3086. doi: 10.1089/scd.2013.0142.
   PubMed Web of Science ®Google Scholar
• Xiang E, Han B, Zhang Q, et al. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther. 2020;11(1):336. doi: 10.1186/s13287-020-01852-y.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shan SK, Guo B, et al. The multi-therapeutic role of MSCs in diabetic nephropathy. Front Endocrinol. 2021;12:671566. doi: 10.3389/fendo.2021.671566.
   PubMed Web of Science ®Google Scholar
• Packham DK, Fraser IR, Kerr PG, et al. Allogeneic mesenchymal precursor cells (MPC) in diabetic nephropathy: a randomized, placebo-controlled, dose escalation study. EBioMedicine. 2016;12:263–269. doi: 10.1016/j.ebiom.2016.09.011.
   PubMed Web of Science ®Google Scholar
• Park JH, Park J, Hwang SH, et al. Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury[J]. Transplant Proc. 2012;44(4):1123–1126. doi: 10.1016/j.transproceed.2012.03.044.
   PubMed Web of Science ®Google Scholar
• Lv S, Cheng J, Sun A, et al. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress. Diabetes Res Clin Pract. 2014;104(1):143–154. doi: 10.1016/j.diabres.2014.01.011.
   PubMed Web of Science ®Google Scholar
• Ezquer F, Giraud-Billoud M, Carpio D, et al. Proregenerative microenvironment triggered by donor mesenchymal stem cells preserves renal function and structure in mice with severe diabetes mellitus. Biomed Res Int. 2015;2015:164703–164723. doi: 10.1155/2015/164703.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42. doi: 10.1016/j.cell.2007.12.018.
   PubMed Web of Science ®Google Scholar
• Barbosa Júnior AdA, Zhou H, Hültenschmidt D, et al. Inhibition of cellular autophagy in proximal tubular cells of the kidney in streptozotocin-diabetic and uninephrectomized rats. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;61(6):359–366. doi: 10.1007/BF02890439.
   PubMedGoogle Scholar
• Song P, Huang W, Onishi A, et al. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glo­merular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am J Physiol Renal Physiol. 2013;317(1):F207–F217. doi: 10.1152/ajprenal.00409.2012.
   Google Scholar
• Wickelgren I. First components found for new kidney filter. Science. 1999;286(5438):225–226. doi: 10.1126/science.286.5438.225.
   PubMed Web of Science ®Google Scholar
• Li J, Zheng S, Ma C, et al. Research progress on exosomes in podocyte injury associated with diabetic kidney disease. Front Endocrinol. 2023;14:1129884. doi: 10.3389/fendo.2023.1129884.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature. 2008;451(7182):1069–1075. doi: 10.1038/nature06639.
   PubMed Web of Science ®Google Scholar
• Li G, Li CX, Xia M, et al. Enhanced epithelial-to-mesenchymal transition associated with lysosome dysfunction in podocytes: role of p62/sequestosome 1 as a signaling hub. Cell Physiol Biochem. 2015;35(5):1773–1786. doi: 10.1159/000373989.
   PubMedGoogle Scholar
• Takagi-Akiba M, Asanuma K, Tanida I, et al. Doxorubicin-induced glomerulosclerosis with proteinuria in GFP-GABARAP transgenic mice. Am J Physiol Renal Physiol. 2012;302(3):F380–9. doi: 10.1152/ajprenal.00502.2010.
   PubMed Web of Science ®Google Scholar
• Yi M, Zhang L, Liu Y, et al. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy. Am J Physiol Renal Physiol. 2017;313(1):F74–f84. doi: 10.1152/ajprenal.00114.2017.
   PubMed Web of Science ®Google Scholar
• Nogueiras R, Habegger KM, Chaudhary N, et al. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev. 2012;92(3):1479–1514. doi: 10.1152/physrev.00022.2011.
   PubMed Web of Science ®Google Scholar
• Lee IH, Cao L, Mostoslavsky R, et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A. 2008;105(9):3374–3379. doi: 10.1073/pnas.0712145105.
   PubMed Web of Science ®Google Scholar
• Daitoku H, Sakamaki J, Fukamizu A. Regulation of FoxO transcription factors by acetylation and protein-protein interactions. Biochim Biophys Acta. 2011;1813(11):1954–1960. doi: 10.1016/j.bbamcr.2011.03.001.
   PubMed Web of Science ®Google Scholar
• Ferdous A, Battiprolu PK, Ni YG, et al. FoxO, autophagy, and cardiac remodeling. J Cardiovasc Transl Res. 2010;3(4):355–364. doi: 10.1007/s12265-010-9200-z.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Mol Cell. 2010;40(2):280–293. doi: 10.1016/j.molcel.2010.09.023.
   PubMed Web of Science ®Google Scholar
• Sengupta A, Molkentin JD, Yutzey KE. FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem. 2009;284(41):28319–28331. doi: 10.1074/jbc.M109.024406.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu LQ, Xu LL, et al. Metformin alleviates renal injury in diabetic rats by inducing Sirt1/FoxO1 autophagic signal axis. Clin Exp Pharmacol Physiol. 2020;47(4):599–608. doi: 10.1111/1440-1681.13226.
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang Y, Ma X, et al. The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats. Mol Biol Rep. 2012;39(9):9085–9093. doi: 10.1007/s11033-012-1780-z.
   PubMed Web of Science ®Google Scholar
• Wang B, Yang Q, Sun YY, et al. Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice[J]. J Cell Mol Med. 2014;18(8):1599–1611. doi: 10.1111/jcmm.12312.
   PubMed Web of Science ®Google Scholar
• Wu Q, Hu Y, Jiang M, et al. Effect of autophagy regulated by Sirt1/FoxO1 pathway on the release of factors promoting thrombosis from vascular endothelial cells[J]. Int J Mol Sci. 2019;20(17):4132. doi: 10.3390/ijms20174132.
   PubMed Web of Science ®Google Scholar
• Ren H, Shao Y, Wu C, et al. Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway. Mol Cell Endocrinol. 2020;500:110628. doi: 10.1016/j.mce.2019.110628.
   PubMed Web of Science ®Google Scholar